Home
Conditions
Fallopian Tube Neoplasms

Clinical trial condition

Fallopian Tube Neoplasms

Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.

610 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Neoplasms trial results

Not yet recruiting

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

NCT07265739

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

NCT07816666

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Research Site Anchorage, Alaska, United States

Research Site Columbia, Maryland, United States

Research Site Detroit, Michigan, United States

Research Site Albany, New York, United States

View all 79 locations

View Trial Details

Not yet recruiting

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

NCT07743164

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

NCT07815704

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: University of Colorado Anschutz Aurora, Colorado, United States

View Trial Details

Not yet recruiting

Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

NCT07811271

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03)

NCT07791732

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Not specified

View Trial Details

Not yet recruiting

Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients

NCT07771400

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations: Hospital Alemán de Buenos Aires Buenos Aires, Argentina

Instituto Alexander Fleming Buenos Aires, Argentina

Fundación Pita Rosario, Argentina

Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo Campo Grande, Mato Grosso do Sul, Brazil

View all 17 locations

View Trial Details

Not yet recruiting

Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer

NCT07772882

Conditions: Adnexal Diseases, Fallopian Tube Cancers, Fallopian Tube Diseases, +12 more
Locations: University of Alabama at Birmingham Womens & Infants Center Birmingham, Alabama, United States

View Trial Details

Not yet recruiting

A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）

NCT07690332

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer

NCT07674615

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Fallopian Tube Neoplasms

Fallopian Tube Neoplasms trial results

Related conditions